Literature DB >> 26407129

Combining 5-Aminolevulinic Acid Fluorescence and Intraoperative Magnetic Resonance Imaging in Glioblastoma Surgery: A Histology-Based Evaluation.

Sonja B Hauser1, Ralf A Kockro, Bertrand Actor, Johannes Sarnthein, René-Ludwig Bernays.   

Abstract

BACKGROUND: Glioblastoma resection guided by 5-aminolevulinic acid (5-ALA) fluorescence and intraoperative magnetic resonance imaging (iMRI) may improve surgical results and prolong survival.
OBJECTIVE: To evaluate 5-ALA fluorescence combined with subsequent low-field iMRI for resection control in glioblastoma surgery.
METHODS: Fourteen patients with suspected glioblastoma suitable for complete resection of contrast-enhancing portions were enrolled. The surgery was carried out using 5-ALA-induced fluorescence and frameless navigation. Areas suspicious for tumor underwent biopsy. After complete resection of fluorescent tissue, low-field iMRI was performed. Areas suspicious for tumor remnant underwent biopsy under navigation guidance and were resected. The histological analysis was blinded.
RESULTS: In 13 of 14 cases, the diagnosis was glioblastoma multiforme. One lymphoma and 1 case without fluorescence were excluded. In 11 of 12 operations, residual contrast enhancement on iMRI was found after complete resection of 5-ALA fluorescent tissue. In 1 case, the iMRI enhancement was in an eloquent area and did not undergo a biopsy. The 28 biopsies of areas suspicious for tumor on iMRI in the remaining 10 cases showed tumor in 39.3%, infiltration zone in 25%, reactive central nervous system tissue in 32.1%, and normal brain in 3.6%. Ninety-three fluorescent and 24 non-fluorescent tissue samples collected before iMRI contained tumor in 95.7% and 87.5%, respectively.
CONCLUSION: 5-ALA fluorescence-guided resection may leave some glioblastoma tissue undetected. MRI might detect areas suspicious for tumor even after complete resection of all fluorescent tissue; however, due to the limited accuracy of iMRI in predicting tumor remnant (64.3%), resection of this tissue has to be considered with caution in eloquent regions.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26407129     DOI: 10.1227/NEU.0000000000001035

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  19 in total

Review 1.  Oncologic Procedures Amenable to Fluorescence-guided Surgery.

Authors:  Kiranya E Tipirneni; Jason M Warram; Lindsay S Moore; Andrew C Prince; Esther de Boer; Aditi H Jani; Irene L Wapnir; Joseph C Liao; Michael Bouvet; Nicole K Behnke; Mary T Hawn; George A Poultsides; Alexander L Vahrmeijer; William R Carroll; Kurt R Zinn; Eben Rosenthal
Journal:  Ann Surg       Date:  2017-07       Impact factor: 12.969

Review 2.  From imaging to biology of glioblastoma: new clinical oncology perspectives to the problem of local recurrence.

Authors:  A Zygogianni; M Protopapa; A Kougioumtzopoulou; F Simopoulou; S Nikoloudi; V Kouloulias
Journal:  Clin Transl Oncol       Date:  2018-01-15       Impact factor: 3.405

Review 3.  Intraoperative 5-ALA fluorescence-guided resection of high-grade glioma leads to greater extent of resection with better outcomes: a systematic review.

Authors:  Tiffany A Eatz; Daniel G Eichberg; Victor M Lu; Long Di; Ricardo J Komotar; Michael E Ivan
Journal:  J Neurooncol       Date:  2022-01-06       Impact factor: 4.130

Review 4.  How Intraoperative Tools and Techniques Have Changed the Approach to Brain Tumor Surgery.

Authors:  Parastou Fatemi; Michael Zhang; Kai J Miller; Pierre Robe; Gordon Li
Journal:  Curr Oncol Rep       Date:  2018-09-26       Impact factor: 5.075

Review 5.  The Long and Winding Road: From the High-Affinity Choline Uptake Site to Clinical Trials for Malignant Brain Tumors.

Authors:  P R Lowenstein; M G Castro
Journal:  Adv Pharmacol       Date:  2016-04-23

Review 6.  Fluorescence Guidance and Intraoperative Adjuvants to Maximize Extent of Resection.

Authors:  Cordelia Orillac; Walter Stummer; Daniel A Orringer
Journal:  Neurosurgery       Date:  2021-10-13       Impact factor: 4.654

Review 7.  Agents for fluorescence-guided glioma surgery: a systematic review of preclinical and clinical results.

Authors:  Joeky T Senders; Ivo S Muskens; Rosalie Schnoor; Aditya V Karhade; David J Cote; Timothy R Smith; Marike L D Broekman
Journal:  Acta Neurochir (Wien)       Date:  2016-11-22       Impact factor: 2.216

8.  5-Aminolevulinic acid-guided resection improves the overall survival of patients with glioblastoma-a comparative cohort study of 343 patients.

Authors:  Asfand Baig Mirza; Ioannis Christodoulides; Jose Pedro Lavrador; Anastasios Giamouriadis; Amisha Vastani; Timothy Boardman; Razna Ahmed; Irena Norman; Christopher Murphy; Sharmila Devi; Francesco Vergani; Richard Gullan; Ranjeev Bhangoo; Keyoumars Ashkan
Journal:  Neurooncol Adv       Date:  2021-03-26

Review 9.  Fluorescence-Guided Surgery for High-Grade Gliomas: State of the Art and New Perspectives.

Authors:  Giuseppe Palmieri; Fabio Cofano; Luca Francesco Salvati; Matteo Monticelli; Pietro Zeppa; Giuseppe Di Perna; Antonio Melcarne; Roberto Altieri; Giuseppe La Rocca; Giovanni Sabatino; Giuseppe Maria Barbagallo; Fulvio Tartara; Francesco Zenga; Diego Garbossa
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

Review 10.  Clinical utility of 5-aminolevulinic acid HCl to better visualize and more completely remove gliomas.

Authors:  Sameer H Halani; D Cory Adamson
Journal:  Onco Targets Ther       Date:  2016-09-12       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.